Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruby Pelingon

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
ACS Infectious Diseases|October 15, 2016
Fluorescent Trimethoprim Conjugate Probes To Assess Drug Accumulation in Wild Type and Mutant Escherichia coliWanida Phetsang, Ruby Pelingon, Mark S Butler, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Mucin Binding Reduces Colistin Antimicrobial ActivityJohnny X Huang, Mark A T Blaskovich, Ruby Pelingon, et al.
Analytical Biochemistry|February 24, 2020
Glycoproteomic measurement of site-specific polysialylationRuby Pelingon, Cassandra L Pegg, Lucia F Zacchi, et al.
Journal of Advanced Research|January 12, 2026
Rapid profiling of polymyxin B susceptibility in gram-negative bacteria with a novel polymyxin-derived fluorescent probeBing Zhang, Wanida Phetsang, Sanjaya Kc, et al.
Molecules (Basel, Switzerland)|February 6, 2019
Structure-Function Studies of Polymyxin B LipononapeptidesAlejandra Gallardo-Godoy, Karl A Hansford, Craig Muldoon, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950Manohar Salla, Mark S Butler, Ruby Pelingon, et al.
Chemmedchem|July 14, 2017
Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome InhibitorsJames R Hill, Rebecca C Coll, Nancy Sue, et al.
Journal of Medicinal Chemistry|January 7, 2016
Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin BAlejandra Gallardo-Godoy, Craig Muldoon, Bernd Becker, et al.
Journal of Medicinal Chemistry|November 24, 2018
Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic ActivityAngie M Jarrad, Chee Wei Ang, Anjan Debnath, et al.
Brain : a Journal of Neurology|October 16, 2025
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease modelsEduardo A Albornoz, Karine Mardon, Rajiv Bhalla, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
ACS Infectious Diseases|October 15, 2016
Fluorescent Trimethoprim Conjugate Probes To Assess Drug Accumulation in Wild Type and Mutant Escherichia coliWanida Phetsang, Ruby Pelingon, Mark S Butler, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Mucin Binding Reduces Colistin Antimicrobial ActivityJohnny X Huang, Mark A T Blaskovich, Ruby Pelingon, et al.
Analytical Biochemistry|February 24, 2020
Glycoproteomic measurement of site-specific polysialylationRuby Pelingon, Cassandra L Pegg, Lucia F Zacchi, et al.
Journal of Advanced Research|January 12, 2026
Rapid profiling of polymyxin B susceptibility in gram-negative bacteria with a novel polymyxin-derived fluorescent probeBing Zhang, Wanida Phetsang, Sanjaya Kc, et al.
Molecules (Basel, Switzerland)|February 6, 2019
Structure-Function Studies of Polymyxin B LipononapeptidesAlejandra Gallardo-Godoy, Karl A Hansford, Craig Muldoon, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950Manohar Salla, Mark S Butler, Ruby Pelingon, et al.
Chemmedchem|July 14, 2017
Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome InhibitorsJames R Hill, Rebecca C Coll, Nancy Sue, et al.
Journal of Medicinal Chemistry|January 7, 2016
Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin BAlejandra Gallardo-Godoy, Craig Muldoon, Bernd Becker, et al.
Journal of Medicinal Chemistry|November 24, 2018
Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic ActivityAngie M Jarrad, Chee Wei Ang, Anjan Debnath, et al.
Brain : a Journal of Neurology|October 16, 2025
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease modelsEduardo A Albornoz, Karine Mardon, Rajiv Bhalla, et al.
Pageof 2